Zik, Jodi https://orcid.org/0000-0003-4260-4227
Hawks, Jessica
Ellingson, Jarrod M.
Elliotte, Eliza
Penner, Anne
Malaska, Colin
Trujillo, Tara
Stoddard, Joel
Funding for this research was provided by:
National Institute of Mental Health and Neurosciences (R25MH125758, K23MH113731, K23MH113731)
Brain and Behavior Research Foundation (Brain and Behavior Research Foundation, Brain and Behavior Research Foundation)
National Institute on Alcohol Abuse and Alcoholism (K23AA026635)
Colorado Center for Drug Discovery, Colorado State University (1100101)
Article History
Accepted: 19 February 2024
First Online: 27 February 2024
Declarations
:
: The authors complied with ethical standards in the treatment of participants. The study was approved by the Colorado Multiple Institutional Review Board and all procedures were in accordance with the ethical standards of the 1964 Helsinki Declaration and its later amendments. Written consent was obtained from all participants. The material reported in this manuscript is original, not previously published, and not under concurrent consideration elsewhere.
: On behalf of all authors, the corresponding author states that there is no conflict of interest.
: JJS has family stock ownership in the following healthcare companies: CVS, AbbVie, Merk, Pfizer, Bristol Myers Squibb, Johnson & Johnson, and Abbot Laboratories. His research has been supported by the US National Institutes of Health, State of Colorado, Brain and Behavior Research Foundation, and Children’s Hospital Foundation. JJS learned of these stocks after contributing to this article. As such, the authors report no competing interests to declare that are relevant to the content of this article.